You are here

CERID Bibliography

Export 120 results:
Author Title Type [ Year(Asc)]
Filters: Author is Gale, Michael  [Clear All Filters]
2007
Daffis S, Samuel MA, Keller BC, Gale M, Diamond MS. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 2007 ;3(7):e106.
Johnson CL, Owen DM, Gale M. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem. 2007 ;282(14):10792-803.
Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, Ye J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A. 2007 ;104(14):5848-53.
Loo Y-M, Gale M. Influenza: fatal immunity and the 1918 virus. Nature. 2007 ;445(7125):267-8.
Mibayashi M, Martinez-Sobrido L, Loo Y-M, Cárdenas WB, Gale M, García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol. 2007 ;81(2):514-24.
Keller BC, Johnson CL, Erickson AKaup, Gale M. Innate immune evasion by hepatitis C virus and West Nile virus. Cytokine Growth Factor Rev. 2007 ;18(5-6):535-44.
Saito T, Gale M. Principles of intracellular viral recognition. Curr Opin Immunol. 2007 ;19(1):17-23.
Wagoner J, Austin M, Green J, Imaizumi T, Casola A, Brasier A, Khabar KSA, Wakita T, Gale M, Polyak SJ. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol. 2007 ;81(1):309-18.
Saito T, Hirai R, Loo Y-M, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 2007 ;104(2):582-7.
Gale M. The role of innate immunity in chronic hepatitis C viral infection. Gastroenterol Hepatol (N Y). 2007 ;3(9):683-4.
Malathi K, Dong B, Gale M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature. 2007 ;448(7155):816-9.
2006
Johnson CL, Gale M. CARD games between virus and host get a new player. Trends Immunol. 2006 ;27(1):1-4.
Cárdenas WB, Loo Y-M, Gale M, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EOllmann, Basler CF. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol. 2006 ;80(11):5168-78.
Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BRG, Silverman RH, Gale M, Diamond MS. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol. 2006 ;80(14):7009-19.
Chien Y, Kim S, Bumeister R, Loo Y-M, Kwon SWon, Johnson CL, Balakireva MG, Romeo Y, Kopelovich L, Gale M, et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell. 2006 ;127(1):157-70.
Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol. 2006 ;80(19):9424-34.
Loo Y-M, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, D Carney S, Wang T, Ishida H, Yoneyama M, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A. 2006 ;103(15):6001-6.
Fredericksen BL, Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol. 2006 ;80(6):2913-23.

Pages